Mahamaya Lifesciences (BOM:544611) ROCE %: 36.45% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:544611 Mahamaya Lifesciences Ltd BOM:544611
16 GF Score
Price ₹166.45
! 4 Warning Signs
View Full Analysis

What is Mahamaya Lifesciences ROCE %?

Mahamaya Lifesciences BOM:544611 16 ROCE % is 36.45% as of Mar. 2026. GuruFocus rates BOM:544611 with a GF Score™ of 16/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mahamaya Lifesciences's annualized ROCE % for the quarter that ended in Mar. 2026 was 36.45%.

Mahamaya Lifesciences  (BOM:544611) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mahamaya Lifesciences ROCE % Related Terms

Mahamaya Lifesciences ROCE % Historical Data

* Premium members only.

The historical data trend for Mahamaya Lifesciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mahamaya Lifesciences ROCE % Chart

Mahamaya Lifesciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
19.56 27.33 37.02 53.07 34.82

Mahamaya Lifesciences Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Mar26
ROCE % Get a 7-Day Free Trial 0.00 0.00 58.99 40.80 36.45
BOM:544611
16GF Score
Mahamaya Lifesciences Ltd BOM:544611
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mahamaya Lifesciences ROCE % Calculation

Mahamaya Lifesciences's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=320.164/( ( (1883.521 - 1316.216) + (3102.802 - 1831.338) )/ 2 )
=320.164/( (567.305+1271.464)/ 2 )
=320.164/919.3845
=34.82 %

Mahamaya Lifesciences's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Mar. 2025 )(Q: Mar. 2026 )
=335.076/( ( (1883.521 - 1316.216) + (3102.802 - 1831.338) )/ 2 )
=335.076/( ( 567.305 + 1271.464 )/ 2 )
=335.076/919.3845
=36.45 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 36.45% mean?
Mahamaya Lifesciences (BOM:544611) has a ROCE % of 36.45% as of Mar. 2026.
Is Mahamaya Lifesciences' ROCE % too high?
Mahamaya Lifesciences' current ROCE % is 36.45%. The Agriculture industry median ROCE % is 9.31. Mahamaya Lifesciences' value of 36.45% is 291.7% above this industry median. Overall, Mahamaya Lifesciences has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Mahamaya Lifesciences' ROCE % compare to CTVA and CF?
Mahamaya Lifesciences' ROCE % of 36.45% can be compared against companies in the Agriculture industry. The industry median ROCE % is 9.31. Mahamaya Lifesciences' value of 36.45% is 291.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Agriculture company?
The median ROCE % among Agriculture companies is 9.31, based on 254 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mahamaya Lifesciences's current ROCE % of 36.45% is 291.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Agriculture industry, the median ROCE % is 9.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mahamaya Lifesciences's current ROCE % is 36.45%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mahamaya Lifesciences stock overvalued right now?
Mahamaya Lifesciences (BOM:544611) has a current ROCE % of 36.45%. The current ROCE % is 36.45% and 291.7% above the Agriculture industry median of 9.31. Mahamaya Lifesciences' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Mahamaya Lifesciences (BOM:544611), the current ROCE % is 36.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mahamaya Lifesciences Business Description

Address Sohna Road, Sector-49, Unit No. 369, 370, 370A & 370B, 3rd Floor, Prime Tower-B1, Spaze ITech Park, Gurugram, HR, IND, 122018
Mahamaya Lifesciences Ltd specializes in the manufacturing of pesticide formulations and supplies bulk formulations catering to both Indian agrochemical companies as well as multinational corporations (MNCs). The company's offerings include Insecticides, Herbicides, and Fungicides. Geographically, it serves multiple Indian states including Punjab, Haryana, Rajasthan, and Uttar Pradesh, and internationally serves countries like the Dominican Republic, Turkey, Egypt, and the UAE. The company generates revenue from the sale of its pesticide formulations.
16GF Score

Get the complete analysis for BOM:544611

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹166.45
Price